Jupiter Life Line Hospitals Limited (NSE:JLHL)
1,438.20
-9.60 (-0.66%)
Sep 3, 2025, 3:30 PM IST
NSE:JLHL Revenue
Jupiter Life Line Hospitals had revenue of 3.48B INR in the quarter ending June 30, 2025, with 21.07% growth. This brings the company's revenue in the last twelve months to 13.21B, up 18.50% year-over-year. In the fiscal year ending March 31, 2025, Jupiter Life Line Hospitals had annual revenue of 12.62B with 17.52% growth.
Revenue (ttm)
13.21B
Revenue Growth
+18.50%
P/S Ratio
7.19
Revenue / Employee
4.67M
Employees
2,828
Market Cap
94.93B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Mar 31, 2025 | 12.62B | 1.88B | 17.52% |
Mar 31, 2024 | 10.73B | 1.81B | 20.22% |
Mar 31, 2023 | 8.93B | 1.56B | 21.13% |
Mar 31, 2022 | 7.37B | 2.47B | 50.35% |
Mar 31, 2021 | 4.90B | 273.24M | 5.90% |
Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Sun Pharmaceutical Industries | 537.77B |
Divi's Laboratories | 96.52B |
Cipla | 274.80B |
Apollo Hospitals Enterprise | 225.51B |
Mankind Pharma | 129.10B |
Zydus Lifesciences | 236.08B |
Fortis Healthcare | 80.94B |
Alkem Laboratories | 133.04B |